Thorsten Rieckmann
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
- Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 22
- PARP inhibition in cancer therapy 7
- Cancer-related Molecular Pathways 5
- Lung Cancer Research Studies 4
-
- DNA Repair Mechanisms 11
- Fibroblast Growth Factor Research 4
- Co-authors
- Malte Kriegs (25 shared papers)Ekkehard Dikomey (14 shared papers)Chia‐Jung Busch (14 shared papers)Cordula Petersen (16 shared papers)Silke Tribius (3 shared papers)Tobias Grob (3 shared papers)Kai Rothkamm (22 shared papers)Beat Trüeb (4 shared papers)
- Journals
- Radiotherapy and Oncology (8 papers)Oncotarget (5 papers)Strahlentherapie und Onkologie (3 papers)Frontiers in Oncology (3 papers)Cancers (3 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Thorsten Rieckmann
48 papers receiving 1.3k citations
Thorsten Rieckmann's Hit Papers
Peers
Comparison fields: 5 of 90
- Otorhinolaryngology 260
- Oncology 496
- Cancer Research 182
- Molecular Biology 651
- Pulmonary and Respiratory Medicine 179
Countries citing papers authored by Thorsten Rieckmann
This map shows the geographic impact of Thorsten Rieckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Rieckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Rieckmann more than expected).
Fields of papers citing papers by Thorsten Rieckmann
This network shows the impact of papers produced by Thorsten Rieckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Rieckmann. The network helps show where Thorsten Rieckmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Thorsten Rieckmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Hit paper breakdown → | 2013 | 252 |
| 2 | 2010 | 95 | |
| 3 | 2012 | 60 | |
| 4 | 2017 | 56 | |
| 5 | 2011 | 49 | |
| 6 | 2014 | 49 | |
| 7 | 2015 | 44 | |
| 8 | 2016 | 42 | |
| 9 | 2019 | 40 | |
| 10 | 2007 | 39 | |
| 11 | 2008 | 37 | |
| 12 | 2012 | 37 | |
| 13 | 2011 | 36 | |
| 14 | 2020 | 35 | |
| 15 | 2013 | 34 | |
| 16 | 2016 | 29 | |
| 17 | 2010 | 27 | |
| 18 | 2004 | 26 | |
| 19 | 2019 | 23 | |
| 20 | 2012 | 20 |
About Thorsten Rieckmann
Thorsten Rieckmann is a scholar working on Oncology, Molecular Biology, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (12 papers), DNA Repair Mechanisms (11 papers), PARP inhibition in cancer therapy (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer-related Molecular Pathways (5 papers), Fibroblast Growth Factor Research (4 papers), Lung Cancer Research Studies (4 papers) and Cervical Cancer and HPV Research (3 papers). The work is most often cited by research in Otorhinolaryngology (260 citations), Oncology (496 citations), Cancer Research (182 citations), Molecular Biology (651 citations) and Pulmonary and Respiratory Medicine (179 citations). Thorsten Rieckmann has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Malte Kriegs, Ekkehard Dikomey, Chia‐Jung Busch, Cordula Petersen, Silke Tribius, Tobias Grob, Kai Rothkamm, Beat Trüeb, Felix Meyer and Jochen Dahm‐Daphi. Their work appears in journals such as Radiotherapy and Oncology, Oncotarget, Strahlentherapie und Onkologie, Frontiers in Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.